Literature DB >> 10802784

Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies.

O L Lopez1, R L Hamilton, J T Becker, S Wisniewski, D I Kaufer, S T DeKosky.   

Abstract

OBJECTIVE: 1) To examine the clinical differences between AD and AD with Lewy bodies (AD+LB); and 2) to determine the accuracy of Consensus guidelines for the clinical diagnosis of dementia with Lewy bodies (DLB) at different levels of dementia severity.
METHODS: The authors examined the clinical characteristics of 185 patients with pathologically diagnosed AD alone and 60 with AD+LB. The relationship between clinical symptoms and AD+LB was determined by multivariate analyses, controlled by age, duration of symptoms, presence of cerebrovascular disease, and dementia severity.
RESULTS: Mild dementia syndrome: No specific clinical symptom was associated with the presence of AD+LB. The sensitivity of the diagnosis of DLB was 62% and specificity was 54%. Moderate dementia syndrome: Extrapyramidal signs (EPS), especially cogwheel rigidity, and major depression were associated with AD+LB. The sensitivity for DLB was 82% and specificity was 31%. Severe dementia syndrome: Cogwheel rigidity and diurnal hypersomnia were associated with AD+LB. The sensitivity for DLB was 93% and specificity was 16%.
CONCLUSIONS: The presence of EPS is not useful in differentiating AD+LB from AD in patients with mild dementia. However, as the disease progressed, they emerge as defining features, especially cogwheel rigidity. The accuracy of AD+LB diagnosis varies according the severity of the dementia syndrome. The low sensitivity and specificity in AD+LB patients with mild dementia suggest that in early stages AD+LB patients do not present the clinical characteristics of DLB. By contrast, the high sensitivity and low specificity for the diagnosis of DLB in moderate/severe dementia stages suggests that AD patients can also have characteristic symptoms of DLB. These results indicate that the antemortem diagnosis of AD+LB is difficult in all dementia stages, and better clinical and biologic differentiations of these entities are needed.

Entities:  

Mesh:

Year:  2000        PMID: 10802784     DOI: 10.1212/wnl.54.9.1780

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Lewy bodies and dementia.

Authors:  D Galasko
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

2.  Comparative analysis of cognitive impairments in lewy body dementia and Alzheimer's disease.

Authors:  I S Preobrazhenskaya; E A Mkhitaryan; N N Yakhno
Journal:  Neurosci Behav Physiol       Date:  2006-01

3.  Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.

Authors:  Guerry M Peavy; Steven D Edland; Belinda M Toole; Lawrence A Hansen; Douglas R Galasko; Ann M Mayo
Journal:  Parkinsonism Relat Disord       Date:  2016-07-21       Impact factor: 4.891

4.  Anosmia is very common in the Lewy body variant of Alzheimer's disease.

Authors:  J M Olichney; C Murphy; C R Hofstetter; K Foster; L A Hansen; L J Thal; R Katzman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

Review 5.  Dementia with Lewy bodies. Review of diagnosis and pharmacologic management.

Authors:  Christopher Frank
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

Review 6.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

7.  Gray matter atrophy associated with extrapyramidal signs in the Lewy body variant of Alzheimer's disease.

Authors:  Seong Hye Choi; Mikel Olabarrieta; Oscar L Lopez; Victoria Maruca; Steven T Dekosky; Ronald L Hamilton; James T Becker
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 8.  Dementia with Lewy bodies.

Authors:  Tanis J Ferman; Bradley F Boeve
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

9.  Low sensitivity in clinical diagnoses of dementia with Lewy bodies.

Authors:  Peter T Nelson; Gregory A Jicha; Richard J Kryscio; Erin L Abner; Frederick A Schmitt; Gregory Cooper; Li O Xu; Charles D Smith; William R Markesbery
Journal:  J Neurol       Date:  2009-10-01       Impact factor: 4.849

10.  Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies.

Authors:  P T Nelson; R J Kryscio; G A Jicha; E L Abner; F A Schmitt; L O Xu; G Cooper; C D Smith; W R Markesbery
Journal:  Neurology       Date:  2009-10-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.